Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction

Alemtuzumab, an anti-CD52 T-cell and B-cell depleting monoclonal antibody, is established for induction therapy in renal transplantation (KTx). We herein provide a comparative analysis between alemtuzumab and basiliximab induction therapy and correlate lymphocyte depletion and recovery with the clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Weissenbacher, Annemarie, Hautz, Theresa, Kimelman, Michael, Oberhuber, Rupert, Ulmer, Hanno, Bösmüller, Claudia, Maglione, Manuel, Schneeberger, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480808/
https://www.ncbi.nlm.nih.gov/pubmed/26171403
http://dx.doi.org/10.1155/2015/985460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480808/
https://www.ncbi.nlm.nih.gov/pubmed/26171403
http://dx.doi.org/10.1155/2015/985460

Ejemplares similares